3152 related articles for article (PubMed ID: 19752408)
1. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
[TBL] [Abstract][Full Text] [Related]
2. The impact of gender on survival amongst patients with implantable cardioverter defibrillators for primary prevention against sudden cardiac death.
Henyan NN; White CM; Gillespie EL; Smith K; Coleman CI; Kluger J
J Intern Med; 2006 Nov; 260(5):467-73. PubMed ID: 17040253
[TBL] [Abstract][Full Text] [Related]
3. Proportion of patients followed in a specialized heart failure clinic needing an implantable cardioverter defibrillator as determined by applying different trial eligibility criteria.
Toma M; McAlister FA; Ezekowitz J; Kimber S; Gulamhusein S; Pantano A; Sivakumaran S; Cujec B; Paterson I; Armstrong PW
Am J Cardiol; 2006 Mar; 97(6):882-5. PubMed ID: 16516594
[TBL] [Abstract][Full Text] [Related]
4. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).
Zareba W; Piotrowicz K; McNitt S; Moss AJ;
Am J Cardiol; 2005 Jun; 95(12):1487-91. PubMed ID: 15950580
[TBL] [Abstract][Full Text] [Related]
5. Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death.
Klein MH; Gold MR
Cardiol Clin; 2008 Aug; 26(3):419-31, vi-vii. PubMed ID: 18538188
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS
Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258
[TBL] [Abstract][Full Text] [Related]
7. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
Wilkoff BL;
Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of implantable cardioverter-defibrillators.
Sanders GD; Hlatky MA; Owens DK
N Engl J Med; 2005 Oct; 353(14):1471-80. PubMed ID: 16207849
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials.
Nanthakumar K; Epstein AE; Kay GN; Plumb VJ; Lee DS
J Am Coll Cardiol; 2004 Dec; 44(11):2166-72. PubMed ID: 15582314
[TBL] [Abstract][Full Text] [Related]
10. Impact of implantable-cardioverter-defibrillator trials on clinical management of patients with heart failure.
Winslow RD; Pinney S; Fuster V
Nat Clin Pract Cardiovasc Med; 2006 Feb; 3(2):86-93. PubMed ID: 16446777
[TBL] [Abstract][Full Text] [Related]
11. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.
Ding L; Hua W; Niu H; Chen K; Zhang S
Europace; 2008 Sep; 10(9):1034-41. PubMed ID: 18559335
[TBL] [Abstract][Full Text] [Related]
12. Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004.
Al-Khatib SM; Sanders GD; Mark DB; Lee KL; Bardy GH; Bigger JT; Buxton AE; Connolly S; Kadish A; Moss A; Feldman AM; Ellenbogen KA; Singh S; Califf RM;
Am Heart J; 2005 Jun; 149(6):1020-34. PubMed ID: 15976783
[TBL] [Abstract][Full Text] [Related]
13. Reducing mortality with device therapy in heart failure patients without ventricular arrhythmias.
Chapa DW; Lee HJ; Kao CW; Friedmann E; Thomas SA; Anderson J; Bardy GH
Am J Crit Care; 2008 Sep; 17(5):443-52; quiz 453. PubMed ID: 18776000
[TBL] [Abstract][Full Text] [Related]
14. Mortality reduction by implantable cardioverter-defibrillators in high-risk patients with heart failure, ischemic heart disease, and new-onset ventricular arrhythmia: an effectiveness study.
Chan PS; Hayward RA
J Am Coll Cardiol; 2005 May; 45(9):1474-81. PubMed ID: 15862422
[TBL] [Abstract][Full Text] [Related]
15. Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in patients with left ventricular systolic dysfunction: 14 years after MADIT.
Franqui-Rivera H; Sotomonte JC
P R Health Sci J; 2011 Jun; 30(2):78-83. PubMed ID: 21682151
[TBL] [Abstract][Full Text] [Related]
16. [The implantable cardioverter/defibrillator].
Kuck KH; Siebels J; Schlüter M; Meinertz T
Herz; 1994 Oct; 19(5):287-93. PubMed ID: 8001901
[TBL] [Abstract][Full Text] [Related]
17. Primary prevention of sudden cardiac death by implantable cardioverter-defibrillator therapy in Chinese patients with heart failure: a single-center experience.
Chen TB; Cheng KA; Gao P; Cheng ZW; Fan JB; Jiang XC; Fang Q
Chin Med J (Engl); 2010 Apr; 123(7):848-51. PubMed ID: 20497676
[TBL] [Abstract][Full Text] [Related]
18. Sex-based differences in cardiac resynchronization therapy and implantable cardioverter defibrillator therapies: effectiveness and use.
Yarnoz MJ; Curtis AB
Cardiol Rev; 2006; 14(6):292-8. PubMed ID: 17053376
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis: age and effectiveness of prophylactic implantable cardioverter-defibrillators.
Santangeli P; Di Biase L; Dello Russo A; Casella M; Bartoletti S; Santarelli P; Pelargonio G; Natale A
Ann Intern Med; 2010 Nov; 153(9):592-9. PubMed ID: 21041579
[TBL] [Abstract][Full Text] [Related]
20. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
